An interventional study of Therapeutic dance in Children With Disabilities, sponsored by University of Valencia. Recruiting at 1 site in Spain. Open to participants aged 3 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by University of Valencia · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The primary aim of this exploratory cluster-randomized trial is to assess the feasibility and acceptability of delivering a school-based group therapeutic dance program through a family-centered approach for children with disabilities and to generate preliminary estimates of intervention effects and outcome variability to inform the design of a future definitive cluster-randomized controlled trial.
No confirmatory effectiveness hypothesis is prespecified for this exploratory trial. Instead, the study will estimate the direction, magnitude, and precision of pre-liminary between-group differences in the primary and secondary clinical outcomes and will characterize feasibility and implementation parameters relevant to a future definitive trial.
This protocol describes the DanceDiversity trial, an exploratory cluster-randomized feasibility trial designed to evaluate the feasibility and acceptability of a school-based, group therapeutic dance intervention delivered through a family-centered approach for children with disabilities, while generating preliminary estimates of its potential clin-ical effects on individualized occupational performance. Methods: A two-arm, paral-lel-group, assessor-blinded, cluster-randomized feasibility trial will be conducted across 6-10 participating schools. All 10 eligible schools will be invited to participate, with 6 schools representing the anticipated minimum recruitment scenario. Participating schools will be allocated in a 1:1 ratio, using restricted randomization stratified by school type, to either the DanceDiversity experimental group (EG) or a waitlist control group (CG). Approximately 36-60 children with disabilities will be enrolled, depending on the number of participating schools. Baseline assessments will occur prior to alloca-tion disclosure. The EG will receive a 29-week therapeutic dance program consisting of two 60-minute group sessions per week, whereas the CG will maintain usual activities and will be offered the intervention following post-intervention assessment. Outcomes will be evaluated by two blinded independent physical therapists. The primary clinical outcome will be individualized occupational performance, measured by the Canadian Occupational Performance Measure (COPM) performance score. Secondary outcomes assessed in both arms will include the COPM satisfaction score, participation, health-related quality of life, gross motor function, functional mobility, functional bal-ance, walking speed, and passive lower-limb range of motion. Goal Attainment Scaling will be evaluated exclusively within the EG as an exploratory individualized outcome. Prospective feasibility criteria covering recruitment, retention, attendance, and inter-vention fidelity, together with perceived session enjoyment, will also be monitored within the EG.
759 studies on the registry are indexed under Nervous System Diseases; 217 are open to participants now.
This study's planned enrollment of 36 is below the median of 55 across 496 interventional studies indexed under Nervous System Diseases.
Browse Nervous System Diseases studies →University of Valencia is the lead sponsor of 357 studies on the registry; 75 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this group will receive DanceDiversity, a manualized, physical therapist-led therapeutic dance intervention delivered over 29 weeks during the academic year (two 60-minute group sessions per week).
Other: Therapeutic dance
Participants in the waitlist control group will continue their usual school-based activities throughout the study period and will be invited to receive the therapeutic dance intervention during the subsequent academic cycle.
The protocol includes two sessions per week of therapeutic dance, during the academic year.
The Canadian Occupational Performance Measure (COPM).
The COPM performance score will be used to assess children's and families' perceptions of performance and satisfaction regarding individualized activity and participation goals. The COPM is a standardized, client-centered, semi-structured interview widely validated in pediatric rehabilitation and designed to identify priorities in meaningful everyday activities. For each identified goal, performance and satisfaction will be rated on a 10-point scale (1 = poor/unsatisfied to 10 = excellent/extremely satisfied). The COPM will be administered as a joint child-caregiver interview rather than through separate self- and proxy-reports.
Time frame: Baseline (pre-intervention) and immediately post-intervention.
Quality of life with the Pediatric Quality of Life Inventory (PEDS QL)
A tool used to measure the health-related quality of life in children and adolescents, both with and without health conditions.
Time frame: Baseline (pre-intervention) and immediately post-intervention.
Gross Motor Function Measure (GMFM-88).
Is an assessment tool designed and evaluated to measure changes in gross motor function over time or with intervention in children with cerebral palsy.
Time frame: Baseline (pre-intervention) and immediately post-intervention.
Pediatric Balance Scale
The scale consists of 14 balance-related test items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56.
Time frame: Baseline (pre-intervention) and immediately post-intervention.
Timed up and go test (TUG)
This test involves a series of actions that assess an individual's mobility and balance. It requires the individual to rise from a seated position in a standard chair, walk a distance of three meters, turn around, walk back to the chair, and sit down again. The time it takes to complete this sequence is recorded.
Time frame: Baseline (pre-intervention) and immediately post-intervention.
Joint ranges
The joint ranges of the hip, knee and ankle in the three planes of movement will be carried out with a goniometer.
Time frame: Baseline (pre-intervention) and immediately post-intervention.
Goal Attainment Scale (GAS).
Goal Attainment Scaling (GAS) is a method of scoring the extent to which patient's individual goals are achieved in the course of intervention.
Time frame: Baseline (pre-intervention) and immediately post-intervention.
Plan to share: Yes — Anonymized data may be shared with other researchers upon a reasonable request made to the project's principal investigator. Study Protocol will be published.
Supporting information: Study protocol, Informed consent form
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Jul 2027, 9 months later.
Of 168 non-industry interventional studies with no phase under Nervous System Diseases, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 57. This study's planned 9 months is below that.
Counting every sponsor, half of 194 studies reached it within 30 months; a quarter within 11 and three quarters within 54.
Nervous System Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
Start moved once since we started tracking on Sep 25, 2026: Sep 2025 → Oct 2026, on Oct 15, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.